| Natera is a diagnostics company with proprietary molecular and bioinformatics technology. Co.'s product offerings include, among others: Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Vistara, a single-gene mutations screening test performed to identify single-gene disorders; Horizon Carrier Screening to determine carrier status for severe genetic diseases that could be passed on to the carrier's children; and Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. We show 19 historical shares outstanding datapoints in our NTRA shares outstanding history coverage, used to compute NTRA market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing NTRA market cap history over the course of time is important for investors
interested in comparing NTRA's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of NTRA versus a peer is one thing; comparing
NTRA market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like NTRA can fluctuate over the course of history.
With this page we aim to empower investors researching NTRA by allowing them to research the NTRA market cap history.